secwatch.observer — SEC 8-K summary
======================================

Issuer:     Foghorn Therapeutics Inc. (FHTX)
CIK:        0001822462
Form:       8-K
Filed at:   2024-12-30T23:59:59+00:00
Accession:  0001628280-24-052539
Event type: leadership
Sentiment:  neutral
Materiality: 0.30
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

Director Adam M. Koppel resigns from Foghorn Therapeutics board
---------------------------------------------------------------

- Adam M. Koppel, M.D., Ph.D., resigned from the Board effective December 29, 2024.
- Resignation not due to any disagreement with the Company or Board.
- Koppel served on the Audit Committee and Nominating and Corporate Governance Committee.
- He was a Class II director with a term expiring at the 2025 Annual Meeting.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1822462/000162828024052539/0001628280-24-052539-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1822462/000162828024052539/fhtx-20241229.htm
  HTML page:      https://secwatch.observer/filing/0001628280-24-052539

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer